Complete response of metastatic cutaneous squamous cell carcinoma to cetuximab plus paclitaxel

European Journal of Dermatology

Volumn 22, Issue 6, 2012, Pages 758-761

  Mecca, Caterina ^a   Ponzetti, Agostino ^a   Caliendo, Virginia ^a   Ciuffreda, Libero ^a   Lista, Patrizia ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Cetuximab; Cisplatin refractory cSCC; Cutaneous squamous cell carcinoma; Second line treatment

Indexed keywords

CETUXIMAB; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ACNE; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DRUG SAFETY; DRUG TOLERABILITY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MALE; MALIGNANT LENTIGO; METASTASIS; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PLEURA METASTASIS; POSITRON EMISSION TOMOGRAPHY; PUNCH BIOPSY; RADIATION DOSE FRACTIONATION; SKIN CARCINOMA; SKIN METASTASIS; TREATMENT RESPONSE; TUMOR INVASION;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; HUMANS; INDUCTION CHEMOTHERAPY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MAINTENANCE CHEMOTHERAPY; MALE; MIDDLE AGED; PACLITAXEL; PLEURAL NEOPLASMS; SKIN NEOPLASMS;

EID: 84877017190     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2012.1845     Document Type: Article

References (35)

1. National Comprehensive Cancer Network (NCCN). Clinical practice guidelines for basal cell and squamous cell skin cancer.
2. Cranmer LD, Engelhardt C, Morgan SS. Treatment of unresectable and metastatic cutaneous squamous cell carcinoma. Oncologist 2010; 15: 1320-8.
3. Weinberg S, Ogle CA, Shim EK, Mdã EK. Metastatic Cutaneous Squamous Cell Carcinoma: An Update. Dermatol Surg 2007; 33: 885-99.
4. Behshad R, Garcia-Zuazaga J, Bordeaux JS, et al. Systemic treatment of locally advanced nonmetastatic cutaneous squamous cell carcinoma: a review of literature. Br J Dermatol 2011; 165: 1169-77.
5. Andruchow JL, Veness MJ, Morgan GJ, et al. Implications For Clinical Staging Of Metastatic Cutaneous Squamous Carcinoma Of The Head And Neck Based On A Multicenter Study Of Treatment Outcomes. Cancer 2006; 106: 1078-83.
6. Brunner M, Veness MJ, Ch'ng S, Elliott M, Clark JR. Distant Metastases From Cutaneous Squamous Cell Carcinoma-Analysis Of AJCC Stage IV. Head Neck 2012 Jan 20. doi: 10.1002/hed.22913. [Epub ahead of print].
7. Veness MJ, Morgan GJ, Palme CE, Gebski V. Surgery And Adjuvant Radiotherapy In Patients With Cutaneous Head And Neck Squamous Cell Carcinoma Metastatic To Lymph Nodes: Combined Treatment Should Be Considered Best Practice. Laryngoscope 2005; 115:870-5.
8. Audet N, Palme CE, Gullane PJ, et al. Cutaneous Metastatic Squamous Cell Carcinoma To The Parotid Gland: Analysis And Outcome. Head Neck 2004; 26: 727-32.
9. Denic S. Preoperative Treatment Of Advanced Skin Carcinoma With Cisplatin And Bleomycin. Am J Clin Oncol 1999; 22: 32-4.
10. Merimsky O, Neudorfer M, Spitzer E, Chaitchik S. Salvage Cisplatin And Adriamycin For Advanced Or Recurrent Basal Or Squamous Cell Carcinoma of The Face. Anticancer Drugs 1992; 3: 481-4.
11. Khansur T, Kennedy A. Cisplatin And 5-Fluorouracil For Advanced Locoregional And Metastatic Squamous Cell Carcinoma Of The Skin. Cancer 1991; 67: 2030-2.
12. Sadek H, Azli N, Wendling JL. Treatment Of Advanced Squamous Cell Carcinoma Of The Skin With Cisplatin, 5-Flourouracil, And Bleomycin. Cancer 1990; 66: 1692-6.
13. Guthrie T Jr, Porubsky E, Luxenberg M, et al. Cisplatin-Based Chemotherapy In Advanced Basal And Squamous Cell Carcinomas Of The Skin: Results In 28 Patients Including 13 Patients Receiving MultiModality Therapy. J Clin Oncol 1990; 8: 342-6.
14. Wollina U, Hansel G, Koch A, Kostler E. Oral Capecitabine And Subcutaneous Ifn-Alpha In Advanced Squamous Cell Carcinoma Of The Skin. J Cancer Res Clin Oncol 2005; 131: 300-4.
15. Cartei G, Interlandi G, Meneghini G, et al. Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged. Am J Clin Oncol 2000; 23: 181-4.
16. Shin DM, Glisson BS, Khuri FR, et al. Phase Ii And Biologic Study Of Interferon Alfa, Retinoic Acid, And Cisplatin In Advanced Squamous Skin Cancer. J Clin Oncol 2002; 20: 364-70.
17. Lippman SM, Parkinson DR, Itri LM, et al. 13-Cis-Retinoic Acid And Interferon Alpha-2a: Effective Combination Therapy For Advanced Squamous Cell Carcinoma Of The Skin. J Natl Cancer Inst 1992; 84: 235-41.
18. Glisson B.S., Kim M.S.K.E.S., Francisco M., et al. Phase II Study Of Gefitinib in PatientsWith Metastatic/Recurrent Squamous Cell Carcinoma Of The Skin. 2006 Asco Annual Meeting Proceedings, J Clin Oncol 2006; 24:5531.
19. Cohen EE, Rosen F, Stadler WM, et al. Phase II Trial Of Zd1839 In Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck. J Clin Oncol 2003; 21: 1980-7.
20. Baltaci M, Fritsch P, Weber F, et al. Treatment With Gefitinib (ZD 1839) In A Patient With Advanced Cutaneous Squamous Cell Carcinoma. Br J Dermatol 2005; 153: 234-6.
21. Read W.L. Squamous carcinoma of the skin responding to erlotinib: Three cases. J Clin Oncol, 2007 ASCO Annual Meeting Proceedings 2007; 25: 16519.
22. Fogarty GB, Conus NM, Chu J, et al. Characterization of the expression and activation of the epidermal growth factor receptor in squamous cell carcinoma of the skin. Br J Dermatol 2007; 156: 92-8.
23. Maubec E, Duvillard P, Velasco V, et al. Immunoistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin. Anticancer Res 2005; 25: 1205-11.
24. Coen E. E. Role Of Epidermal Growth Factor Receptor Pathway-Targeted Therapy In Patients With Recurrent And/Or Metastatic Squamous Cell Carcinoma Of The Head And Neck. J Clin Oncol 2006; 24: 2659-65.
25. Maubec E, Petrow P, Scheer-Senyarich I, et al. Phase II study of cetuximab as first-line single drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol 2011; 29: 3419-25.
26. Giacchero D, Barrière J, Benezery K, et al. Efficacy of cetuximab for unresectable or advanced cutaneous squamous cell carcinoma. A report of eight cases. Clin Oncol (R Coll Radiol) 2011; 23: 716-8.
27. Arnold AW, Bruckner-Tuderman L, Zuger C, Itin PH. Cetuximab Therapy Of Metastasizing Cutaneous Squamous Cell Carcinoma In A Patient With Severe Recessive Dystrophic Epidermolysis Bullosa. Dermatology 2009; 219: 80-3.
28. Kim S, Eleff M, Nicolaou N. Cetuximab As Primary Treatment For Cutaneous Squamous Cell Carcinoma To The Neck. Head Neck 2011; 33: 286-8.
29. Göppner D, Nekwasil S, Franke I, Gollnick H, Leverkus M. Successful Combination Therapy Of A Locally Advanced Squamous Cell Carcinoma Of The Skin With Cetuximab and irradiation. JDDG 2010: 826-8.
30. Miller K, Sherman W, Ratner D. Complete clinical response to Cetuximab in a patient with metastatic squamous cell carcinoma. Dermatol Surg 2010; 36: 2069-73.
31. Jalili A, Pinc A, Pieczkowski F, et al. Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma. J Dtsch Dermatol Ges 2008; 6: 1066.
32. Suen JK, Bressler L, Shord SS, et al. Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab. Anticancer Drugs 2007; 18: 827-9.
33. Baumann JE, Eaton KD, Martins RG. Treatment of recurrent squamous cell carcinoma of the skin with cetuximab. Arch Dermatol 2007; 143: 889-92.
34. Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. Chemotherapy-induced peripheral neuropathy (CIPN): an update. Crit Rev Oncol Hematol 2011; 82: 51-77.
35. Kivisaari AK, Kallajoki M, Ala-aho R, et al. Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma. Br J Dermatol 2010; 163: 726-35.